ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,257.40
0.08%
S&P ASX All Technology
3,854.10
0.67%
Brent Oil
77.115
0.80%
US Dollar vs AUD
1.59555
-0.76%
Bitcoin
101,415.56
3.14%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cingulate Inc (CING) Share Price

Cingulate Inc

Cingulate Inc (CING)

NASDAQ
5.0109
-0.0391
( -0.77% )
Updated: 01:59:56
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
5.0109
Bid
5.02
Offer
5.08
Volume
18,410
5.01 Day's Range 5.18
1.8001 52 Week Range 101.76
Market Cap
16.096M
Previous Close
5.05
Open
5.15
Last Trade
90
@
5.05
Last Trade Time
02:06:16
Financial Volume
US$ 94,213
VWAP
5.1175
Average Volume (3m)
136,973
Shares Outstanding
3,212,233
Dividend Yield
-
PE Ratio
-0.69
Earnings Per Share (EPS)
-7.33
Revenue
-
Net Profit
-23.54M

About Cingulate Inc

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions cha... Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cingulate.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Cingulate Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CING. The last closing price for Cingulate was US$5.05. Over the last year, Cingulate shares have traded in a share price range of US$ 1.8001 to US$ 101.76.

Cingulate currently has 3,212,233 shares in issue. The market capitalisation of Cingulate is US$16.22 million. Cingulate has a price to earnings ratio (PE ratio) of -0.69.

Ask ADVFN Intelligence (AI)

CING Latest News

More News

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

KANSAS CITY, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

23 December 2024
GlobeNewswire Inc.

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

KANSAS CITY, Kan., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

07 November 2024
GlobeNewswire Inc.

Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show

KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed...

09 October 2024
GlobeNewswire Inc.

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

KANSAS CITY, Kan., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

12 September 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

03 September 2024
Edgar (US Regulatory)

Form 8-K - Current report

03 September 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

31 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

29 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

29 August 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

28 August 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.14092.89322381934.875.24.631584975.02235855CS
40.860920.74457831334.155.24980794.68371723CS
120.17093.530991735544.845.22963.021369734.24844898CS
260.810919.30714285714.220.831.8001211780310.40476902CS
52-73.3491-93.605283307878.36101.761.8001124453111.23683814CS
156-606.9891-99.18122549026127081.800169411394.71649907CS
260-1194.9891-99.582425120012361.8001693608111.0095244CS

CING - Frequently Asked Questions (FAQ)

What is the current Cingulate share price?
The current share price of Cingulate is US$ 5.0109
How many Cingulate shares are in issue?
Cingulate has 3,212,233 shares in issue
What is the market cap of Cingulate?
The market capitalisation of Cingulate is USD 16.22M
What is the 1 year trading range for Cingulate share price?
Cingulate has traded in the range of US$ 1.8001 to US$ 101.76 during the past year
What is the PE ratio of Cingulate?
The price to earnings ratio of Cingulate is -0.69
What is the reporting currency for Cingulate?
Cingulate reports financial results in USD
What is the latest annual profit for Cingulate?
The latest annual profit of Cingulate is USD -23.54M
What is the registered address of Cingulate?
The registered address for Cingulate is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Cingulate website address?
The website address for Cingulate is www.cingulate.com
Which industry sector does Cingulate operate in?
Cingulate operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPRCSciSparc Ltd
US$ 1.36
(157.62%)
91.45M
MEGLMagic Empire Global Limited
US$ 1.0585
(88.31%)
67.78M
GFAIGuardforce AI Company Ltd
US$ 3.18
(64.77%)
31.93M
ARBEArbe Robotics Ltd
US$ 4.02
(52.85%)
67.66M
BOXLBoxlight Corporation
US$ 0.6789
(47.59%)
4.38M
BLRXBioLineRx Ltd
US$ 0.156
(-43.02%)
19.97M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0856
(-42.08%)
13.91M
GCTKGlucoTrack Inc
US$ 0.1761
(-39.96%)
7.99M
LUNALuna Innovations Incorporated
US$ 1.3717
(-33.09%)
1.28M
ACONAclarion Inc
US$ 0.1998
(-33.04%)
15.1M
CNSPCNS Pharmaceuticals Inc
US$ 0.1403
(14.07%)
155.79M
SPRCSciSparc Ltd
US$ 1.36
(157.62%)
91.45M
MEGLMagic Empire Global Limited
US$ 1.0585
(88.31%)
67.78M
ARBEArbe Robotics Ltd
US$ 4.02
(52.85%)
67.66M
NVDANVIDIA Corporation
US$ 150.00
(3.83%)
66.99M

CING Discussion

View Posts
tw0122 tw0122 2 months ago
Flipped it already 90% of these stocks reverse split money printing scams. Trade technicals 
👍️0
PonkenPlonken PonkenPlonken 2 months ago
its a scam
👍️0
tw0122 tw0122 2 months ago
$4.67 Keep an eye ADHD anxiety low floater 
👍️0
Monksdream Monksdream 4 months ago
CING under $10

👍️0
tbonaces80 tbonaces80 4 months ago
Trash. Told you. Dilute. Get ready for class action.
👍️0
Invest-in-America Invest-in-America 5 months ago
STREAM DECK ELGATO: Thanks!! (Never heard of it!)
👍️0
TIMGZ TIMGZ 5 months ago
THAT WAS CORRECT*****TOMORROW WILL BE A BETTER DAY. CHECK OUT "STREAM DECK ELGATO' FOR QUICK FAST IN AND OUT IF U HAVE NOT ALREADY. JUST FOUND OUT ABOUT IT
👍️0
Invest-in-America Invest-in-America 5 months ago
Indeed, Dude. And on that note, I would estimate --- right after I tossed Reena969's @INM pick into my 'E-Turd' search box, & saw it up in the Pre-M today by 145% --- that I would have had circa 15-minutes to buy it, & then dump it, when it (rapidly) hit about 500% up. And, if YOU are on the EAST COAST, then you already have a leg-up on this game behind WeBull, & the otherwise natural 3-hours TIME differential for doing this stuff.

PS: By the way, Ms. Reena posted on Orion's that she herself did NOT attempt to play that @INM 'casino table' during today's Pre-M --- despite her being the entire iHub site's very FIRST to post about it.
👍️0
TIMGZ TIMGZ 5 months ago
MORE TO COME*******BUT HAVE TO BE VERY QUICK TO TAKE PROFITS******DUMPING IS OUTRAGEOUS
👍️0
Invest-in-America Invest-in-America 5 months ago
@INM: Me too, Tim!! (And, I thought I had DISCIPLINED myself --- during the last 3-years, or so --- to immediately JUMP when iHub's Ms. "Reena969" announces in any day's Pre-M, e.g., "XYZP, it's running!")
👍️0
TIMGZ TIMGZ 5 months ago
INM *****EPIC MOVE BUT MISSED IT.
👍️0
Invest-in-America Invest-in-America 5 months ago
CING: Pretty good, finally, Capt. Tim --- behind my very SLOW-MOVING @TLS stock, which looks like it might run into the Post-M somewhat. (And I almost jumped-on ihub's "Reena969" Pre-M @INM monster pick --- which crashed gloriously in the Open, however. But, anyone COULD have scored 3-times their money in the Pre-M, where @INM hit circa 500% up..)
👍️0
TIMGZ TIMGZ 5 months ago
that is correct******how was trading for you today
👍️0
tbonaces80 tbonaces80 5 months ago
What did I say. They are diluting with zero revenue. Short
👍️0
Invest-in-America Invest-in-America 5 months ago
Indeed, Capt. Tim! (And right now, there goes that TGL, already on Mars; trying to find something about other than TGL's "Request to Withdraw Registration" statement of a few days ago --- i.e., that clever ploy of NOT dumping more stocks to the Market.)
👍️0
tbonaces80 tbonaces80 5 months ago
If u haven’t followed this CEO rant and figured out their-moves then day trade it. The move was massively made and then they release an s-1. Again. June 2025 if your read the news. Short answer is-short this with stops till it goes to .35 again in a year. Our desk knows and we know Wainwright. Scammers and unable to make the right call
👍️0
TIMGZ TIMGZ 5 months ago
MONK SAYING**** THE PRICE IS WHAT THE MARKET SAYS**** I OVERLOOKED "SOND" THIS MORNING WITH LESS THAN 50,000 VOLUME AND MISSED IT. HEY, WELCOME, WE LEARN EVERYDAY.


DID U CAUGHT SOME "CINGW" LAST FRIDAY 1000%
👍️0
Invest-in-America Invest-in-America 5 months ago
CING: Bad day for me, Capt. Tim!! (Wish I NEVER got out of bed today.)

Then there's that scamming @ALZN firm, PR'ing the IDENTICAL (so-called) "news" three times since this Aug. 6th!! (And yet it soars to 600+%!!)
👍️0
TIMGZ TIMGZ 5 months ago
WAKE UP BRO OR TRADING ALREADY. STAY BLESSED AND HAPPY WEEK TRADING
👍️0
Vance Vance 5 months ago
There's not even that many shares to short, perhaps you have the wrong board.
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
54 MILLION SHORT IN THE LAST TWO SESSIONS..THEY HAVE BEEN BUILDING THEIR POSITIONS, FREAKS THAT SAY SHORTS IN TROUBLE ARE CLUELESS...THEY ARE READY TO PULL THE RUG TO FILL THE GAP
👍️0
Awl416 Awl416 5 months ago
Well they could’ve done it at 3 bucks verse 15 or whatever the filing says

Shorts still nervous who knows where this goes
👍️0
tbonaces80 tbonaces80 5 months ago
Reverse split—stock offer-reverse split-stock offer. Like clockwork
👍️0
da_stock_analyst da_stock_analyst 5 months ago
Would be awesome
👍️ 2
RAlbert RAlbert 5 months ago
$150 price target. Easy money less than million shares outstanding.
👍️0
da_stock_analyst da_stock_analyst 5 months ago
#CING 🔥 this stock having monster run! whats next? $CING
👍️0
gmoney305 gmoney305 5 months ago
going to fill the gap from 25-40 look at the daily chart and the 200 ema !
👍️ 1
trader_ron trader_ron 5 months ago
Made my year, awesome awesome run $$$$$$$ :)
👍️0
amitgupta amitgupta 5 months ago
No revenue , FDA you know how it works
Target $1

How much money in this drug? lol
👍️0
RAlbert RAlbert 5 months ago
Monday is interested by with having low available shared. $50 likely possible
👍️ 2
Triple nickle Triple nickle 5 months ago
Don’t have ya on ignore bro
👍️0
harry crumb harry crumb 5 months ago
Congrats! Shorts got shafted, luvn it here lol
👍️0
harry crumb harry crumb 5 months ago
Bought 4.75-5.50 sold 12-12.50, oh well still made a sweet amount of wealth $$$$$$
We may reload the dip next week, profits will be taken as you see in after hours folks
👍️0
Invest-in-America Invest-in-America 5 months ago
CING: Regarding their latest ADHD Patent "news", what this firm has right now does NOT even qualify as an FDA-approved "CANDIDATE" drug. And, if it eventually DOES qualify as such, this firm must then conduct the likely several YEARS of laboratory, animal, & Phase-1, Phase-2, Phase-3 HUMAN trials necessary for consideration by the FDA as an ACTUAL therapeutic treatment for ADHD, or any other mental or Psychiatric afflictions of Mankind.
CANDIDATE DRUGS
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
Invest-in-America Invest-in-America 5 months ago
CING: "NOT" so easy, fellow --- who has me on iHub's "IGNORE" setting. Hey, MONSTER CONGRATS to all who scored big MONEY behind this typical 'DRUG-CANDIDATES-CARNIVAL-SHOW-COMPANY'. However, this CING firm has NOT conducted even a PHASE-1 human trial for their 'Patented' ADHD routine. All they have right now is a "CANDIDATE" drug routine for ADHD --- and nothing else!! I.e., just like the @TSOI & @HALB firms, they squander their time & energy merely seeking 'PATENTS' for whatever, around the Globe!!
https://www.globenewswire.com/news-release/2024/08/15/2930828/0/en/Cingulate-Issued-European-Patent-for-Lead-Asset-CTx-1301-for-the-Treatment-of-ADHD.html
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
DrHigh DrHigh 5 months ago
CONGRATS BURN THOSE F@CKERS!!!!
👍️0
tbonaces80 tbonaces80 5 months ago
Yuppppp. I’m out 3/4 nice check to come home to. $297k. Thank you
👍️0
Invest-in-America Invest-in-America 5 months ago
CING: Was their now EU-Patented treatment PROVEN to work in Phase-3 Human Trials --- and to what extent, vs. the Placebo & & Standard-of-Care control groups???
👍️0
Triple nickle Triple nickle 5 months ago
Cing 35.00 easy
👍️0
Awl416 Awl416 5 months ago
Oh my
👍️0
Awl416 Awl416 5 months ago
Don’t mess with the professionals. 100m yesterday someone is making a bag load of cash. Unbelievable
👍️0
Awl416 Awl416 5 months ago
Oh geeeeeez
👍️0
Awl416 Awl416 5 months ago
LOL shorts frying on a beautiful smoker. COOKED
👍️0
PirateLeviathan8 PirateLeviathan8 5 months ago
i go out by opening
👍️0
Awl416 Awl416 5 months ago
Burnt to a crisp
👍️0
trader_ron trader_ron 5 months ago
Run away train $$$$$$$
👍️0
Monksdream Monksdream 5 months ago
Early Barchart 100

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
SolarRevolution SolarRevolution 5 months ago
Up 90% in pre market answers all the questions!

$$$

:D
👍️0
Awl416 Awl416 5 months ago
Uh oh
👍️0
juggernutt juggernutt 5 months ago
Over 100 million shares traded in one day on this stock makes no sense. If there wasn’t any dilution going on, it should’ve skyrocketed.
👍️0

Your Recent History

NASDAQ
CING
Cingulate
NASDAQ
IRDMW
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads